1. Home
  2. Resources
  3. SAP Tables
  4. ZFDB_RNDC14 - SMX: FDB NDC Master Data - Attributes of a Packaged Product

SAP Table ZFDB_RNDC14

SMX: FDB NDC Master Data - Attributes of a Packaged Product

ZFDB_RNDC14 (SMX: FDB NDC Master Data - Attributes of a Packaged Product) is a standard table in SAP R\3 ERP systems. Below you can find the technical details of the fields that make up this table. Key fields are marked in blue.

Additionally we provide an overview of foreign key relationships, if any, that link ZFDB_RNDC14 to other SAP tables.

ZFDB_RNDC14 table fields

Field Data element Checktable Datatype Length Decimals
MANDT Client MANDT CLNT 3 0
NDC SMX: FDB National Drug Code (NDC) Stored Raw ZFDB_NDC CHAR 11 0
LBLRID SMX: FDB Labeler Identifier ZFDB_LBLRID ZFDB_RLBLRID3 CHAR 6 0
GCN_SEQNO SMX: FDB GCN - Clinical Formulation ID ( (Stable ID) ZFDB_GCN_SEQNO ZFDB_RGCNSEQ4 CHAR 6 0
PS SMX: FDB Package Size ZFDB_PS CHAR 12 0
DF SMX: FDB Drug Form Code ZFDB_DF CHAR 1 0
1 each (tablets, kits, etc)
2 milliliters (liquids)
3 grams (solids)
AD SMX: FDB NDC Additional Descriptor ZFDB_AD CHAR 20 0
LN SMX: FDB NDC Label Name ZFDB_LN CHAR 30 0
BN SMX: FDB NDC Brand Name ZFDB_BN CHAR 30 0
PNDC SMX: FDB Previous National Drug Code ZFDB_PNDC CHAR 11 0
REPNDC SMX: FDB Replacement National Drug Code ZFDB_REPNDC CHAR 11 0
NDCFI SMX: FDB NDC Format Indicator ZFDB_NDCFI CHAR 1 0
0 PIN 5-4-2 (99999-9999-99) -> 5-4-2 (99999999999)
1 NDC - 4-4-2 (9999-9999-99) -> 5-4-2 (09999999999)
2 NDC - 5-3-2 (99999-999-99) -> 5-4-2 (99999099999)
3 NDC - 5-4-1 (99999-9999-9) -> 5-4-2 (99999999909)
4 UPC - 5-5 (99999-99999) -> 5-4-2 (99999099999)
5 UPC - 5-5 (99999-99999) -> 5-4-2 (99999999909)
6 UPC - 5-5 (99999-99999) -> 5-4-2 (99999999990)
7 HRI - 4-6 (9999-999999) -> 5-4-2 (09999999999)
DADDNC SMX: FDB NDC Date of Add ZFDB_DADDNC DATS 8 0
DUPDC SMX: FDB NDC Date of Update ZFDB_DUPDC DATS 8 0
DESI SMX: FDB FDA DESI Drug Indicator ZFDB_DESI CHAR 1 0
NULL Product never declared DESI
0 DESI at one point in time, but no longer
1 DESI
DESDTEC SMX: FDB DESI Status Change Effective Date ZFDB_DESDTEC DATS 8 0
DESI2 SMX: FDB FDA DESI2 Drug Indicator ZFDB_DESI2 CHAR 1 0
NULL Product never declared DESI2
0 DESI2 at one point in time, but no longer
1 DESI2 as specified in the HCFA 1990 Appended list
DES2DTEC SMX: FDB DESI2 Status Change Effective Date ZFDB_DES2DTEC DATS 8 0
DEA SMX: FDB Drug Enforcement Administration Code ZFDB_DEA CHAR 1 0
0 No control
1 LSD, Heroin, Marijuana - Research only
2 Morphine, Meperidine, Amphetamines, etc., most potential for
3 Aspirin/Codeine, etc., less abused
4 Diazepam, etc., potential abuse
5 Controlled sale by pharmacy only
CL SMX: FDB Drug Class ZFDB_CL CHAR 1 0
O Over-the-counter. Prescription not req'd per product label
F Prescription required per the product labeling
GPI Dummy function in length 1 DUMMY CHAR 1 0
HOSP SMX: FDB Hospital Selection Indicator ZFDB_HOSP CHAR 1 0
0 Not on hospital subset
1 On hospital subset
INNOV SMX: FDB Innovator Indicator ZFDB_INNOV CHAR 1 0
0 Default�non-innovator drug
1 Innovator
IPI SMX: FDB Institutional Product Indicator ZFDB_IPI CHAR 1 0
0 Not Institutional
1 Institutional
MINI SMX: FDB Mini Selection Indicator ZFDB_MINI CHAR 1 0
0 Not on MINI subset
1 On MINI subset
MAINT SMX: FDB Maintenance Drug Indicator ZFDB_MAINT CHAR 1 0
NULL Not a maintenance drug
1 Maintenance drug
OBC SMX: FDB Orange Book Code (2-Char) ZFDB_OBC CHAR 2 0
AA Products with no known bioequivalence problems in convention
AB Products meeting necessary bioequivalence requirements.
AN Solutions and powders for aerosolization that are marketed f
AO Injectable oils with identical active ingredients, concentra
AP Injectable aqueous solutions including dry powders, concentr
AT Topical products therapeutically equivalent in same dosage f
B Products with A or B codes previously assigned; new informat
BC Controlled-release tablets, controlled-release capsules, and
BD Active ingredients and dosage forms with documented bioequiv
BE Enteric coated dosage forms unless proven otherwise to be eq
BN Products in aerosol-nebulizer drug delivery systems that are
BP Active ingredients and dosage forms with potential bioequiva
BR Suppositories or enemas for systemic use unless proven to be
BS Products having drug standard deficiencies.
BT Topical products with bioequivalence problems.
BX Insufficient data to determine therapeutic equivalence.
ZA Particular pharmaceutical entity (GCN) looked at but particu
ZB Particular pharmaceutical entity was not evaluated.
ZC Pharmaceutical entity and labeler evaluated but no therapeut
OBSDTEC SMX: FDB Obsolete Date ZFDB_OBSDTEC DATS 8 0
PPI SMX: FDB Patient Package Insert Indicator ZFDB_PPI CHAR 1 0
NULL Not required
1 Patient Package Insert Required
STPK SMX: FDB Standard Package Indicator ZFDB_STPK CHAR 1 0
0 Standard package
1 All Other Package Sizes
REPACK SMX: FDB Repackaged Indicator ZFDB_REPACK CHAR 1 0
0 Not repackaged
1 Repackaged
TOP200 SMX: FDB Top 200 Drugs Indicator ZFDB_TOP200 CHAR 3 0
000 All Other Drugs
001 Top 200 Drugs in order of rank
UD SMX: FDB Unit Dose Indicator ZFDB_UD CHAR 1 0
0 All Other Products
1 Unit Dose
CSP SMX: FDB Case Pack ZFDB_CSP CHAR 7 0
NDL_GDGE SMX: FDB Needle Gauge ZFDB_NDL_GDGE CHAR 6 0
NDL_LNGTH SMX: FDB Needle Length ZFDB_NDL_LNGTH CHAR 6 0
SYR_CPCTY SMX: FDB Syringe Capacity (ml) ZFDB_SYR_CPCTY CHAR 6 0
SHLF_PCK SMX: FDB Shelf Pack ZFDB_SHLF_PCK CHAR 7 0
SHIPPER SMX: FDB Shipper Quantity ZFDB_SHIPPER CHAR 7 0
HCFA_FDA HCFA FDA Therapeutic Equivalency Code (aka Orange Book Code) ZFDB_HCFA_FDA CHAR 2 0
AA Products with no known bioequivalence problems in convention
AB Products meeting necessary bioequivalence requirements.
AN Solutions and powders for aerosolization that are marketed f
AO Injectable oils with identical active ingredients, concentra
AP Injectable aqueous solutions including dry powders, concentr
AT Topical products therapeutically equivalent in same dosage f
B Products with A or B codes previously assigned; new informat
BC Controlled-release tablets, controlled-release capsules, and
BD Active ingredients and dosage forms with documented bioequiv
BE Enteric coated dosage forms unless proven otherwise to be eq
BN Products in aerosol-nebulizer drug delivery systems that are
BP Active ingredients and dosage forms with potential bioequiva
BR Suppositories or enemas for systemic use unless proven to be
BS Products having drug standard deficiencies.
BT Topical products with bioequivalence problems.
BX Insufficient data to determine therapeutic equivalence.
NR Not Rated by the Orange Book
HCFA_UNIT SMX: FDB HCFA Unit Type Indicator ZFDB_HCFA_UNIT CHAR 3 0
AHF Antihemophilic Factor
CAP Capsule
EA Each
GM Gram
ML Milliliter
SUP Suppository
TAB Tablet
TDP Transdermal Patch
HCFA_PS SMX: FDB HCFA Units Per Package Size ZFDB_HCFA_PS CHAR 12 0
HCFA_APPC SMX: FDB HCFA Approval Date ZFDB_HCFA_APPC DATS 8 0
HCFA_MRKC SMX: FDB HCFA Market Entry Date ZFDB_HCFA_MRKC DATS 8 0
HCFA_TRMC SMX: FDB HCFA Termination Date ZFDB_HCFA_TRMC DATS 8 0
HCFA_TYP SMX: FDB HCFA Drug Type Indicator ZFDB_HCFA_TYP CHAR 1 0
NULL Not provided by HCFA
1 Designated by the FDA as prescription only
2 Over the Counter
HCFA_DESC1 HCFA DESI Effective Date ZFDB_HCFA_DESC1 DATS 8 0
HCFA_DESI1 SMX: FDB HCFA DESI Code ZFDB_HCFA_DESI1 CHAR 1 0
0 NDC not on HCFA tape (no information submitted by manufactur
2 Safe and Effective or non-DESI
3 DESI/IRS Drugs Under Review (No NOOH issued)
4 Less than effective DESI/IRS Drugs for Some Indications
5 Less than effective DESI/IRS Drugs for All Indications
6 Less than effective DESI/IRS Drugs Removed from the Market
UU SMX: FDB Unit of Use Indicator ZFDB_UU CHAR 1 0
0 All Other Products
1 Unit of Use
PD SMX: FDB Package Description ZFDB_PD CHAR 10 0
AER BR.ACT Aerosol, Breath Activated
AER REF Aerosol, Refill Unit
AER W/ADAP Aerosol with Adapter
AMP W/DEV Ampul with Device
AMPUL Ampul
AMPUL/KIT Ampul/Kit
BAG Bag
BLIST PACK Blister Pack
BOTTLE Bottle
BOX Box
CAN Can
CANISTER Canister
CANIT RFU Canister, Refill Unit
CARTRIDGE Cartridge
CUP Cup
**DISPENSE Dispenser
DOSE-PACK Dispensing Pack
DROP BTL Dropper Bottle
DRUM Drum
FLEX CONT Flexible Container
GLASS CONT Glass Container
JAR Jar
KIT Kit
KIT-REFILL Kit-Refill
**N/A Not Applicable
**PACKAGE Package
PACKET Packet
PF APPLI Applicator, Pre-filled
ROLL Roll
**SOLN BTL Solution Bottle
SQUEEZ BTL Squeeze Bottle
SYRINGE Syringe
**TINE Tine
TUBE Tube
TUBE STICK Tube Stick
**TUBE/JAR Tube/Jar
TUBE/KIT Tube/Kit
VIAL Vial
VIAL/KIT Vial/Kit
LN25 SMX: FDB Label Name - 25 Characters ZFDB_LN25 CHAR 25 0
LN25I SMX: FDB Label Name - 25 Generic Name Use Indicator ZFDB_LN25I CHAR 1 0
0 Brand name abbreviation up to 12 bytes within LN25
1 Generic name abbreviation up to 12 bytes within LN25
GPIDC Dummy function in length 1 DUMMY CHAR 1 0
BBDC Dummy function in length 1 DUMMY CHAR 1 0
HOME SMX: FDB Home Health Indicator ZFDB_HOME CHAR 1 0
0 Not on HOME subset
1 On HOME subset
INPCKI SMX: FDB Inner Package Indicator ZFDB_INPCKI CHAR 1 0
0 All Others
1 Inner Package
OUTPCKI SMX: FDB Outer Package Indicator ZFDB_OUTPCKI CHAR 1 0
0 All Others
1 Outer Package
OBC_EXP SMX: FDB Expanded Orange Book Code ZFDB_OBC_EXP CHAR 2 0
AA Products with no known bioequivalence problems in conv. form
AB Products meeting necessary bioequivalence requirements.
AN Solutions and powders for aerosolization that are marketed..
AO Injectable oils with identical active ingredients, concentra
AP Injectable aqueous solutions including dry powders, concentr
AT Topical products therapeutically equivalent in same dosage f
B Products with A or B codes previously assigned; new informat
BC Controlled-release tablets, controlled-release capsules, and
BD Active ingredients and dosage forms with documented bioequiv
BE Enteric coated dosage forms unless proven otherwise to be eq
BN Products in aerosol-nebulizer drug delivery systems that are
BP Active ingredients and dosage forms with potential bioequiva
BR Suppositories or enemas for systemic use unless proven to be
BS Products having drug standard deficiencies.
BT Topical products with bioequivalence problems.
BX Insufficient data to determine therapeutic equivalence.
ZA Particular pharmaceutical entity (GCN) looked at but particu
ZB Particular pharmaceutical entity was not evaluated.
ZC Pharmaceutical entity and labeler evaluated but no therapeut
PS_EQUIV SMX: FDB Package Size Equivalent Value ZFDB_PS_EQUIV CHAR 12 0
PLBLR SMX: FDB Private Labeler Indicator ZFDB_PLBLR CHAR 1 0
0 All Others
1 Private Labeler
TOP50GEN SMX: FDB Top 50 Generics ZFDB_TOP50GEN CHAR 2 0
0 Not in the top 50
00 Not in the top 50
01 Ranking within the top 50
OBC3 SMX: FDB Orange Book Code; 3-Byte Version ZFDB_OBC3 CHAR 3 0
AA Products with no known bioequivalence problems in convention
AB Products meeting necessary bioequivalence requirements.
AB1 Products meeting necessary bioequivalence requirements.
AB2 Products meeting necessary bioequivalence requirements.
AB3 Products meeting necessary bioequivalence requirements.
AN Solutions and powders for aerosolization
AO Injectable oils with identical active ingredients, concentra
AP Injectable aqueous solutions including dry powders, concentr
AT Topical products therapeutically equivalent in same dosage f
B Products with A or B codes previously assigned; new informat
BC Controlled-release tablets, controlled-release capsules, and
BD Active ingredients and dosage forms with documented bioequiv
BE Enteric coated dosage forms unless proven otherwise to be eq
BN Products in aerosol-nebulizer drug delivery systems that are
BP Active ingredients and dosage forms with potential bioequiva
BR Suppositories or enemas for systemic use unless proven to be
BS Products having drug standard deficiencies.
BT Topical products with bioequivalence problems.
BX Insufficient data to determine therapeutic equivalence.
ZA Particular pharmaceutical entity (GCN) looked at but particu
ZB Particular pharmaceutical entity was not evaluated.
ZC Pharmaceutical entity and labeler evaluated but no therapeut
GMI SMX: FDB Generic Manufacturer Indicator ZFDB_GMI CHAR 1 0
0 Non-drug item, such as medical supplies and bulk chemicals
1 Generic manufacturer
2 Brand manufacturer
3 Alternative (niche) manufacturer (no longer being applied)
4 Indeterminate (Labelers that are not otherwise classified)
GNI SMX: FDB Generic Name Indicator ZFDB_GNI CHAR 1 0
0 Non-drug item, such as medical supplies and bulk chemicals
1 Generically named
2 Brand named
GSI Dummy function in length 1 DUMMY CHAR 1 0
GTI SMX: FDB Therapeutic Equivalence Indicator ZFDB_GTI CHAR 1 0
0 Non-drug item, such as medical supplies and bulk chemicals
1 Orange Book B-rated drug product
2 Single source
3 Orange Book A-rated drug product
4 Product not listed in the Orange Book
NDCGI1 SMX: FDB Multi-Source/Single Source Indicator ZFBD_NDCGI1 CHAR 1 0
1 Multiple source
2 Single source
HCFA_DC SMX: FDB HCFA Drug Category ZFDB_HCFA_DC CHAR 1 0
NULL Unspecified
S Single Source
I Innovator Multi-source
N Non-Innovator Multi-source
LN60 SMX: FDB Label Name - 60 Characters ZFDB_LN60 CHAR 60 0

ZFDB_RNDC14 foreign key relationships

Table Field Foreign key table Foreign key field Check table Check field
ZFDB_RNDC14 GCN_SEQNO ZFDB_RNDC14 MANDT ZFDB_RGCNSEQ4 SMX: FDB Clinical Formulation ID Attributes MANDT
ZFDB_RNDC14 GCN_SEQNO ZFDB_RNDC14 GCN_SEQNO ZFDB_RGCNSEQ4 SMX: FDB Clinical Formulation ID Attributes GCN_SEQNO
ZFDB_RNDC14 LBLRID ZFDB_RNDC14 MANDT ZFDB_RLBLRID3 SMX: FDB Labeler Identifier Description MANDT
ZFDB_RNDC14 LBLRID ZFDB_RNDC14 LBLRID ZFDB_RLBLRID3 SMX: FDB Labeler Identifier Description LBLRID